Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
236
Enrollment
INDUSTRY
Sponsor class
Conditions
Keratoconjunctivitis Sicca
Interventions
DRUG:
CF101
Sponsor
Can-Fite BioPharma